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Campylobacter jejuni, the most frequent cause of food-borne bacterial gastroenteritis,
is a fastidious organism when grown in the laboratory. Oxygen is required for growth,
despite the presence of the metabolic mechanism for anaerobic respiration. Amino acid
auxotrophies are variably reported and energy metabolism can occur through several
electron donor/acceptor combinations. Overall, the picture is one of a flexible, but
vulnerable metabolism. To understandCampylobactermetabolism, we have constructed
a fully curated, metabolic model for the reference organismM1 (our variant is M1cam) and
validated it through laboratory experiments. Our results show that M1cam is auxotrophic
for methionine, niacinamide, and pantothenate. There are complete biosynthesis
pathways for all amino acids except methionine and it can produce energy, but not
biomass, in the absence of oxygen. M1cam will grow in DMEM/F-12 defined media but
not in the previously published Campylobacter specific defined media tested. Using the
model, we identified potential auxotrophies and substrates that may improve growth.
With this information, we designed simple defined media containing inorganic salts,
the auxotrophic substrates, L-methionine, niacinamide, and pantothenate, pyruvate and
additional amino acids L-cysteine, L-serine, and L-glutamine for growth enhancement.
Our defined media supports a 1.75-fold higher growth rate than Brucella broth after 48
h at 37◦C and sustains the growth of other Campylobacter jejuni strains. This media
can be used to design reproducible assays that can help in better understanding the
adaptation, stress resistance, and the virulence mechanisms of this pathogen. We have
shown that with a well-curated metabolic model it is possible to design a media to grow
this fastidious organism. This has implications for the investigation of newCampylobacter
species defined through metagenomics, such as C. infans.
Keywords: Campylobacter jejuni, genome-scale metabolic model, linear programming, defined growth media,
metabolism, auxotrophy, metabolic network
1. INTRODUCTION
1.1. Background
Campylobacter, the leading cause of acute bacterial gastroenteritis, is Gram-negative,
microaerophilic, spiral-shaped, highly motile bacteria (Debruyne et al., 2008; Lastovica et al.,
2014). The epidemiology in low to middle income countries is poorly studied but appears to be
different from that in high-income countries (Platts-Mills and Kosek, 2014). Acquisition in high
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income countries is mainly through ingestion of contaminated
poultry, milk, or water (Altekruse et al., 1998; Butzler,
2004; Ruiz-Palacios, 2007; Westrell et al., 2009). The genus
Campylobacter can be divided into 28 species (Wilkinson et al.,
2018) (and further into sub-species), that may vary in their
temperature, oxygen, and nutrient requirements for growth.
The most common species associated with campylobacteriosis
is Campylobacter jejuni, with Campylobacter coli reported in
10–25% of cases. The disease is economically important, with
an estimated cost to the UK economy at around £50 million
(Tam and O’Brien, 2016). Under reporting of cases (Gibbons
et al., 2014) and failure to consider sequelae (Mangen et al.,
2016), however, makes this an underestimate. Disease symptoms
in humans may vary, but in the UK, they include diarrhea,
fever, and abdominal pain. The sequelae however include
colitis, reactive arthritis, and Miller-Fisher and Guillain-Barré
syndromes (Jacobs et al., 1996; Blaser and Engberg, 2008).
Along with an increase in reported incidence, and improving
diagnosis, resistance to antibiotics is becoming a concern
(Châtre et al., 2010; Deckert et al., 2010; Gormley et al.,
2010). The diagnosis of campylobacteriosis has depended, until
recently, on culture-based methods, but these methods may
not grow all Campylobacter spp. causing human infections
(Buss et al., 2019; Bian et al., 2020). An understanding of
how to grow these “non-culturable” Campylobacter spp. may
change our understanding of campylobacterosis, particularly
in low income countries where the burden is high and
predominantly occurs in children (Platts-Mills and Kosek,
2014). The conditions used in diagnostic laboratories vary,
but commonly include a gas mix of 5–10% O2, 5–10% CO2
and 80–85% N2 (with some mixes also containing H2), a
temperature of 37◦C or 42◦C, with complex media containing
blood, peptone, meat, or yeast extract (Hsieh et al., 2018).
These media are not chemically defined, and may vary from
batch to batch, making comparisons between strains and the
growth conditions used for isolation difficult. The use of recently
developed commercial PCR assays have improved diagnosis,
but new variants would not be detected. As metagenomic
methods are not yet freely available, a more permissive culture
media is required for comprehensive burden studies and
pathogen discovery.
1.1.1. Growth Culture
Until the introduction of selective agars (Skirrow, 1977;
Lauwers et al., 1978), filtration techniques were used to
isolate Campylobacter (Dekeyser et al., 1972; Butzler et al.,
1973). An understanding of the microaerophilic nature of
Campylobacter (Hoffman et al., 1979) improved the culture
still further. The development of Campylobacter specific culture
media (Corry et al., 1995; Davis and DiRita, 2008; Kim
et al., 2016) now represents the state of the art, however, the
availability of a permissive defined media for Campylobacter spp.
remains elusive. Although defined media have been described
(Dickgiesser and Czylwik, 1985; Tenover et al., 1985; Guccione
et al., 2010; Alazzam et al., 2011), the use of complex,
undefined media (Wright et al., 2009; Liu et al., 2012) persists,
because of the need to culture a wide range of Campylobacter
strains that demonstrate different auxotrophies (Dickgiesser
and Czylwik, 1985; Tenover and Patton, 1987; Alazzam et al.,
2011; Vorwerk et al., 2014). A method to investigate the
ingredients required for a permissive media is clearly needed.
One way to do this is to look at the metabolic requirements of
campylobacter cells in terms of nutrient sources, biomass, and
energy production.
1.1.2. Campylobacter Metabolism
Campylobacter spp. have considerable flexibility for energy
production in terms of electron acceptors and donors that can
be used in the electron transport chain (ETC); in addition
to the ability to utilize O2 as an electron acceptor, nitrate,
nitrite, and fumarate have also been described as alternatives.
Campylobacter spp. would therefore appear to have the potential
to carry out anaerobic respiration (Sellars et al., 2002; Kelly,
2008), however, many strains do not grow in the absence of
oxygen, even in the presence of alternative electron acceptors
(Sellars et al., 2002). The reason for this oxygen dependency
is not absolutely certain but is likely to be related to oxygen
dependent DNA synthesis enzymes (Jordan and Reichard, 1998;
Kelly, 2008). The ETC also has a high degree of flexibility
in terms of electron donors, with pyruvate, H2, formate, and
succinate having been reported to fulfil this role (Sellars et al.,
2002; Kelly, 2008). In contrast to the ETC, other areas of central
metabolism are quite limited, when compared with that of most
other gut bacteria. In particular, they lack transporters for many
small carbohydrates, with two essential enzymes in the upper
limb of the Embden–Meyerhof–Parnas pathway (glucokinase
and phosphofructokinase) being absent. Most strains lack the
Entner-Doudoroff pathway, and the oxidative steps of the
oxidative pentose phosphate pathway are also absent (although
the non-oxidative branch is present Velayudhan and Kelly,
2002; Line et al., 2010). The absence of carbohydrate utilization
pathways suggests that amino acids and tricarboxylic acid (TCA)
cycle intermediates act as the primary nutrient sources for
C. jejuni (Westfall et al., 1986; Velayudhan et al., 2004; Del
Rocio Leon-Kempis et al., 2006; Stahl et al., 2012; Hofreuter,
2014), but detailed knowledge as to how such substrates may
be utilized, remains limited. Furthermore, the ability of this
organism to survive right through the food chain, suggests it
can utilize a variety of metabolic strategies. Our understanding
of Campylobacter physiology, thus, remains limited, with most
descriptions of Campylobacter physiology being based on a single
isolate of C. jejuni NCTC11168 (Carrillo et al., 2004; Alazzam
et al., 2011; Metris et al., 2011; Xu et al., 2015; van der Hooft et al.,
2018).
1.2. Metabolic Modeling
Genome-scale metabolic models (GSMs) describe the metabolic
interactions of an organism with its environment, based on a
reaction network ultimately inferred from enzymes encoded by
the genome. Their analyses enable an investigation of metabolic
behavior of the whole system, rather than individual reactions
and pathways, and can be used to identify mechanistic links
between cellular genotype and metabolic phenotype.
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Genome-scale metabolic models overview
Over the last two decades, GSMs have become a valuable tool to analyze cellular behavior under different biological conditions, to design drug targets, to
investigate metabolic interactions in microbial communities, and to design defined growth media (reviewed in Liu et al., 2010; Zhang and Hua, 2016; Kim et al.,
2017; Gu et al., 2019). GSMs can now be used to inform experimental design and to provide a rationale for experimental observations (Zampieri and Sauer, 2016;
Villanova et al., 2017; van der Ark et al., 2018).
Construction of GSMs starts with the identification of enzymes and transport proteins from an annotated genome. Reactions catalyzed by enzymes thus identified,
are further characterized by their stoichiometry and assumed (ir)reversibility. Such information can usually be obtained from a number of on-line databases including
databases such as BioCyc (Caspi et al., 2015; Karp et al., 2017), MetaCyc (Caspi et al., 2013, 2017), KEGG (Ogata et al., 1999; Kanehisa and Goto, 2000; Kanehisa
et al., 2006), BIGG (Schellenberger et al., 2009), SEED (DeJongh et al., 2007), and BRENDA (Barthelmes et al., 2007).
In addition to defining the properties of internal reactions, it is, for all practical purposes, necessary to identify the properties of transport processes, representing
the consumption and production of compounds in the assumed environment. Compounds present in the environment are referred to as external (or sometimes
boundary) metabolites, otherwise they are referred to as internal metabolites. Reactions that only involve internal metabolites are therefore internal reactions, while
those which involve internal and external metabolites are transport reactions. Although gene annotation with regard to enzymes is usually well-defined, annotation of
transporters tends to be less comprehensive. Experimental investigations involving growth on defined media thus proves a useful independent method to infer the
presence of transport processes, as well as providing useful data for subsequent analyses of the model.
Despite the fundamental importance of online databases, any reconstruction based solely upon these is likely to exhibit a number of problems, the most common
of which are: missing gene-protein-reaction (GPR) associations, inconsistent naming of metabolites, and reaction identifiers, incorrect reaction stoichiometries, and
reversibility, which propagates to the draft model. Thus, in order to represent a realistic representation of a given organism, an initial draft model will require refinement
and curation by the user. The curation process usually begins with correcting reaction stoichiometries and reversibility to ensure that the model follows the law of
mass and energy conservation, followed by checking consistency of identifiers, and identifying missing reactions by “gap-filling.” Such gap-filling may often lead to
an updated gene annotation. One area of metabolism that requires special attention is the electron transport chain, to ensure that translocated protons are correctly
assigned to their location in the cell or the environment.
Usually, large-scale metabolic models such as GSMs, are analyzed using constraint based linear programming (LP) approaches (Fell and Small, 1986; Varma and
Palsson, 1993, 1994), an optimization technique that assigns fluxes to reactions, assuming that the system is at steady state, according to some objective function,
and subject to one or more defined constraints. Typical objective functions are either maximization of growth rate, or minimization of total flux in the system, and
constraints are used to apply upper or lower limits on reactions, and commonly to specify the export of one or more product as defined.
1.2.1. Aims of the Current Study
The aim of this study is to explore Campylobacter spp.
nutrient requirements through the analysis of a newly created
genome scale model of C. jejuni (M1Cam) with experimental
validation. In doing so we define new, chemically defined, media
compositions that will serve as a basis for further modeling and
experimental studies of this organism.
2. MATERIALS AND METHODS
2.1. Model Construction
The model was developed in an iterative manner, as illustrated
in Figure 1, from the available gene sequence of C. jejuniM1cam
(https://www.ncbi.nlm.nih.gov/nuccore/CP012149). Genes were
predicted and annotated, and used to construct a strain specific
Pathway/Genome database (PGDB) for C. jejuni M1cam. This
was used as the basis for the model which was structured in a
modular fashion as described by Poolman et al. (2009), Poolman
et al. (2013), Hartman et al. (2014), and Ahmad et al. (2017). It
consists of:
1. A “top-level” module defining some basic properties and
importing the other modules as described;
2. A “PGDB reactions” module with a set of reactions directly
imported from the strain-specific PGDB which was subjected
to revision as described in 2.1.3.
3. “Media transporter” module describing the import and export
of substrates to/from the medium.
4. “Biomass transporter” module describing the export of
biomass precursors andmetabolites produced as side products
of biomass synthesis for which there are no known
degradation pathways, also called “sink transporters.”
5. The ETC module describing stoichiometries of all
ETC reactions.
6. Additional reactions required for the generation of biomass
precursors, not reported in the PGDB.
2.1.1. Draft Reconstruction
Gene prediction and annotation was carried out using
Prodigal (Hyatt et al., 2010) version 2.6.31 and Prokka
(Seemann, 2014) version 1.142 respectively, with default
cutoff scores.
The “Pathologic component” of Pathway Tools (Karp et al.,
2002, 2015) version 23.0 andMetaCyc (Caspi et al., 2017) version
23.0 was used to generate the strain-specific Pathway/Genome
databases (PGDB), from the annotated genome sequence. The
pathway hole filler component (Green and Karp, 2004) of
Pathway Tools was used to automatically fill pathway holes in
PGDB. Pathways were inferred using the pathway prediction
algorithm (Karp et al., 2011) with a default cutoff score of 0.15.
Missing genes and GPR associations (see sections 3.1.1), were
curated manually with reference to BLAST (Camacho et al.,
2009) and the online databases KEGG (Ogata et al., 1999), Gene
Ontology terms (Ashburner et al., 2000), BRENDA (Jeske et al.,
2018), Pfam (El-Gebali et al., 2018), RHEA (Morgat et al., 2019),
and String v11 accessed 2019 (Szklarczyk et al., 2018).
All the reactions from PGDB were extracted, using the
ScrumPy (Poolman, 2006), metabolic modeling package, version
1254, to populate the “PGDB reactions” module described above,
and to generate the initial draft model.
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FIGURE 1 | Pipeline for genome-scale metabolic model construction used in this study.
2.1.2. Defining System Boundaries
Media transporters were assigned for import of 33 organic
substrates, out of 38 organic substrates in the DMEM/F-12
medium (Table S1). Transporters for the remaining five organic
substrates, choline chloride, folic acid, lipoic acid, thymidine, and
vitamin B12 (cobalamine) were not included because metabolic
routes were not present for these metabolites in the PGDB.
Transporters were assigned for exchange of the gases O2, CO2,
H2, NH4 and H2S between the environment and the system and
for the export of metabolic by-products, such as acetate, lactate,
and succinate.
Biomass transporters were defined for the export of
biomass components as individual components (amino acids,
lipopolysacharides, peptidoglycan, nucleotides, vitamins, etc.), as
described by Thiele et al. (2005) andMetris et al. (2011). Note that
in contrast to these authors who represented biomass as a single
lumped reaction, we assigned biomass transporters to individual
biomass components, and subsequently set their relative fluxes to
represent the observed biomass composition. There are five sink
transporters added to the model for export of by-products from
biomass synthesis [eg. adenosyl-4-methylthio-2-oxobutanoate
produced during biotin synthesis (Metris et al., 2011)].
2.1.3. Curation and Theoretical Validation
The atomic balance of individual reactions were determined
and all the reactions in the model were balanced with respect
to carbon (C), nitrogen (N), phosphorus (P), and sulfur (S),
iron (Fe), sodium (Na), oxygen (O), proton (H), and charge.
Metabolites with unknown atomic compositions or generic
compounds and reactions involved with such metabolites were
replaced, where possible, by balanced reactions with known
atomic composition of metabolites. For example, reactions
involved with generic compounds (e.g., Alcohols) were replaced
with specific metabolites and the stoichiometric coefficient
balanced on both sides of the reaction. Reactions involved with
non-metabolic species (e.g., tRNA, RNA) were excluded from the
model. Similarly, reactions were corrected for reversibility so that
the model is not able to generate energy (in the form of ATP
and NAD(P)H) in absence of a mass flux through the system.
Thus, the model is ensured to follow the laws of mass and energy
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conservation, and is free from stoichiometric inconsistencies
(Gevorgyan et al., 2008).
2.2. Model Analysis
2.2.1. Linear Programming Formulation
Except where noted otherwise, model analysis was undertaken
using appropriate variants of the linear program defined as:
minimise :
∑
|v|
subject to:


N · v = 0
vi..j = bi..j
vk..l ≥ 0 (see below)
vATPase = A
vOtx ≤ Otxmax
(1)
Where v is the vector of all reaction fluxes and N is the
stoichiometry matrix; the objective is to minimize the sum of
all (absolute) flux values (including transporters), subject to the
constraints: Nv = 0 (steady-state assumption), vi..j = bi..j defines
flux in biomass transporters, as described in section 2.1.2, vk..l
defines fluxes in the reactions importing media components,
as described in section 2.1.2, vATPase = A defines flux in a
hypothetical ATPase reaction in order to account for a growth
and non-growth associated maintenance cost and vOtx ≤ Otxmax
defines a maximummicroaerophilic O2 consumption rate. A was
assigned a value of 16mmol/g DW/hr (Varma and Palsson, 1994),
and Otxmax (= 5 mmol/g DW/hr) (Metris et al., 2011).
2.2.2. Identification of Substrate Auxotrophies
Substrate auxotrophies were determined, using the model, by
repeatedly attempting to solve Equation (1) with individual
media transporters (vk..l) set to zero, one at a time. Failure to
obtain a solution was taken as demonstrating auxotrophy
with respect to the component whose transporter was
thus constrained.
2.3. Model Curation and Refinement From
Experimental Observation
Although Campylobacter spp. was successfully cultured in the
DMEM/F-12 medium (section 2.4), the initial model could
not account for the production of all biomass components
from these nutrients. These components were identified by
modifying Equation (1) to account for the production of a single
biomass component, sequentially. Additional reactions were then
identified by their presence in other Campylobacter spp. specific
biochemical databases in Biocyc and KEGG, literature surveys,
and with reference to BLAST (Camacho et al., 2009). Once
identified, these reactions were used to populate the “Additional
Reactions” module described above.
Initial model analysis suggested that biotin and asparagine
were essential nutrients, although this was found not to be the
case in the experimental investigation. This discrepancy was due
to gaps in the biosynthesis pathways of biotin and asparagine.
Gap-filling reactions were identified, based on a literature study
on biotin synthesis (Stok and Voss, 2000; Manandhar and
Cronan, 2017) and BlastP analysis, and were added to the
“Additional Reactions” module as above.
Conversely, initial model analysis suggested that niacinamide
was not an essential nutrient, although subsequent experimental
investigation showed that this was not the case. In order to
identify spurious reactions in the model responsible for this
heterotrophy, Equation (1) was modified to represent production
of niacinamide, utilizing the other media components. Reactions
in the resulting solution for which no GPR could be identified
were removed, thus bringing model behavior into alignment with
our experimentally observed behavior.
2.4. Experimental Conditions
2.4.1. Materials
Brucella broth was purchased from Sigma-Aldrich (Sigma-
Aldrich, Poole, UK) and Brucella agar from BD (Becton,
Dickinson U.K. Limited). Gibco Dulbecco’s Modified Eagle
Medium/Nutrient Mixture F-12 (DMEM/F-12) media with no
added phenol red, was purchased from Thermo Fisher Scientific
(Thermo Fisher Scientific, Darmstadt, Germany). All chemicals
were of commercial analytical grade and obtained from Sigma-
Aldrich. All solutions, except amino acids and vitamins, were
made every week, sterile filtered (0.22µM, Fisher-Scientific, UK),
and kept at −4◦C until needed. Amino acids and vitamins were
prepared immediately before use.
2.4.2. Bacterial Strains Used
C. jejuni M1 has a published genome sequence (Friis et al.,
2010) and is a well-studied laboratory model organism from a
well-documented case of direct transmission between poultry
and humans. The M1 used in this study was obtained from the
Department of Veterinary Medicine, Cambridge University, and
annotated as M1cam (de Vries et al., 2015), an “M1” strain which
differs from the M1 reference strain (published by Friis et al.,
2010) by 50 SNPs (insertions/deletions and true SNPs) (de Vries
et al., 2015).
The other 7 strains, selected from different clades, according
to Champion et al. (2005) and Stabler et al. (2013), were tested
for their ability to grow in the final defined medium. These
were: 81116 (NCTC11828), Calf 3, 11168H, 81-176, 12912,
RM1221, and M1, obtained from the London School of Hygiene
and Tropical Medicine. Strains were stored at −80◦C using
Protect - Multipurpose Microorganism Preservation System
vials (Technical Service Consultants Ltd, Lancashire, UK) or
MicrobankTM cryotubes (Pro-Lab Diagnostics, Merseyside, UK).
2.4.3. Culture Conditions
All strains were grown under microaerophilic conditions (10%
O2 [v/v], 5%CO2 [v/v], 85%N2 [v/v]), using an anaerobic cabinet
and gas supply (BOC Ltd, Surrey, UK), on Brucella broth agar
plates, for 48 h at 37◦C, except those tested in the Department of
Veterinary Medicine, Cambridge University, which were grown
at 42◦C using a gas mix of hydrogen (5% O2 [v/v], 5% H2 [v/v],
5% CO2 [v/v], 85%N2 [v/v]), also using an anaerobic cabinet and
gas supply (BOC Ltd, Surrey, UK).
All C. jejuni strains were harvested from agar plates and
inoculated with a starting optical density (OD) OD600 of
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approximately 0.004 in Brucella broth, incubated with shaking
(180 rpm) using the same temperature and gas supply indicated
previously, to an OD600nm of 0.6 (approximately 2.8 ×
109 CFU/ml). Cultures with OD600 different to 0.6 were
standardized to that value using sterile PBS. After 20 h, 1.7 mL
of this culture was collected, washed twice and resuspended in
1.7 mL of sterile PBS. Each one of the media tested in our study
was inoculated in triplicate at 1% (100 µL in 10 mL of media),
using C. jejuni washed cells. Cultures were then incubated
microaerobically for 48 h with shaking (180 rpm), under the
same temperature and gas conditions stated above, and growth
was assessed daily, measuring OD600 in triplicate of each of the
technical replicates, using a plate reader (FLUOstar R© Omega,
BMG Labtech Ltd, Aylesbury, UK). For this purpose, cultures
were sampled in a class II cabinet and returned immediately to
the anaerobic cabinet. All experiments performed in this study
were repeated three times, each time using a new starting culture,
prepared from glycerol stock, and with freshly made simple
defined media.
2.4.4. Checks for Contamination
To confirm the identity of the experimental organisms, typical
cellular morphology was checked using x1000 bright field
microscopy of carbol fuchsin stained cultures and whole genome
sequencing (WGS) was performed on selected isolates. C. jejuni
M1cam genomic DNA for WGS was extracted using Maxwell R©
RSC Cultured Cells DNA Kit. DNA extracts were converted
into a Nextera library for sequencing on an Illumina NextSeq
500 platform and genomes were assembled using Velvet de-novo
genomic assembler and then subjected to multi-locus sequence
typing (MLST).
2.4.5. Media Design and Confirmation of
Auxotrophies
A modification of DMEM/F-12, not including glucose, was used
as the starting point to develop our defined media for C. jejuni
M1cam (Table S1). The inorganic substrates in our media were
kept in the same concentrations present in the original DMEM/F-
12 media formulation. To achieve a simple defined media,
non-essential substrates identified by the model analysis, were
gradually removed from the media, and growth, measured as
OD, was compared to that of growth in Brucella broth (0.58 ±
0.06 at 24 h) and synthetic DMEM/F-12 media (0.38 ± 0.01 at
24 h). Removal of substrates in media design were compensated
for the net amount of N and S, by increasing the concentration
of remaining substrates proportionally to ensure that the total N
and S was equal or higher than the original formulation.
Substrate auxotrophy was confirmed when removal of
substrate could not support growth of M1cam. Growth was
monitored over longer incubation times (up to 144 h) to confirm
auxotrophy of the compounds tested. If no growth was obtained,
experiments were repeated, to confirm results.
2.4.6. Media Testing
The media to be tested was made fresh on the day of
the inoculation. After addition of all components and before
adjusting the final volume to 100 mL using purified water, the pH
of each of the minimal media tested in this study was measured
using a pH meter [LAQUAtwin pH Meter PH-22 (HORIBA
Advanced Techno Co., Ltd., Kyoto, Japan)] and adjusted to pH
7 using 1M NaOH or 1M HCl solutions. To maintain sterility,
work was carried out in a class II microbiological safety cabinet,
and 10mL ofmedia was filtered into each of the four 50mL sterile
cell culture flasks (Sigma-Aldrich, Poole, UK), closed with their
filter caps and kept at 37◦C until inoculation. Maintaining media
at 37◦C until inoculation proved to be very important to obtain
reproducible results. Finally, in order to compare our results with
previously published defined media, we also tested growth of
C. jejuni M1cam in the defined media given by Guccione et al.
(2010) and Alazzam et al. (2011).
3. RESULTS
3.1. Model Building and Analysis
3.1.1. Pathway/Genome Databases
The automatically generated C. jejuni M1cam PGDB comprised
of 228 pathways with a total 1,366 reactions, including 22
transport reactions, and 1,009 compounds. There were 291
reactions without any assigned gene and were inferred from
pathway prediction algorithm. This also included reactions that
were essential for biomass productions in the model. There
were also genes that encoded metabolic enzymes but were not
associated with reactions. The reason for the missing GPR
association was mainly: (i) information necessary to attribute a
particular reaction to specific gene was missing in the annotated
file (ii) though the gene product had been annotated it was not
detected by the Pathologic software. Reactions, particularly those
inferred as essential for biomass production, without any gene
association were revisited to establish GPR relation (see 2.1.1)
where possible. Table S2 lists GPR relationships that have been
curated in the PGDB. Curated PGDB, after being re-inferred
using pathway prediction algorithm, comprises a total 262
pathways, 1,581 reactions, and 1,104 compounds (summarized
in Table 1 along with other prokaryotic PGDBs) and is available
from Pathway Tools Registry and https://data.quadram.ac.uk/
dipali.singh/CJM1cam_DB/.
TABLE 1 | Main content of C. jejuni M1cam Pathway/Genome database along
with other prokaryotic databases.
Content/
Strains
C. jejuni C. jejuni H. pylori P. aeruginosa Escherichia coli
M1cam M1 26695 PAO1 K-12 (MG1655)
PGDB
curation level
Tier 2 Tier 3 Tier 2 Tier 3 Tier 1
Total
genes
1,679 1,675 1,610 5,677 4,501
Total
pathways
262 228 152 405 433
Total
reactions
1,581 1,005 970 1,833 2,852
Total
compounds
1,104 746 708 1,285 2,965
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3.1.2. Model Properties
The curated model consists of 994 reactions. The number is
less than that of the initial draft model generated from the
PGDB due to removal of reactions involved with non-metabolic
species and those of unknown atomic composition, as described
in 2.1.3. 76% of reactions in the model have gene associations,
6% are spontaneous, while the remainder are inferred by the
gap filling algorithm or added after careful curation. The model
includes 115 transporters, 968 internal metabolites and 93
external metabolites, summarized in Table 2.
3.1.3. Model Analysis—Biomass Production
The solution to Equation (1), with DMEM/F-12 media, has
a total of 326 reactions, including transporters. There are
165 essential for biomass production: removal of any one of
these results in Equation (1) having no feasible solution. The
solution has no net import flux of amino acids, leucine, arginine,
histidine, valine, asparagine, phenylalanine, alanine, threonine,
tyrosine, tryptophan, and lysine (i.e., flux in these amino
acid media transporters were equal to flux in their respective
biomass transporters). There was, however, notable net import
of pyruvate, as a carbon source, and the amino acids, aspartate,
serine, glutamine, and proline; Acetate, succinate, NH4 and CO2
were among the excreted by-products. The model is able to
account for ATP generation under anaerobic conditions through
oxidative phosphorylation, using nitrate or fumarate electron
acceptors. However, it is not able to generate biomass in the
absence of O2.
3.1.4. Model Analysis—Identification of Substrate
Auxotrophy
Out of the 33 organic substrates tested in the model, 30 substrates
were identified as non-essential. The remaining three substrates,
methionine, pantothenate and niacinamide (after the curation
based on experimental observation in 2.3) were identified
as auxotrophic. The pathways for the de-novo biosynthesis
of these metabolites were absent in the PGDB and thus the
model. These included homoserine O-succinyltransferase
and methionine synthase from the methionine biosynthesis
pathway, 3-methyl-2-oxobutanoate hydroxymethyltrasferase,
TABLE 2 | Summary of genome-scale metabolic model of C. jejuni M1cam.
Total no. of reactions 994
Total no. of transporters 115
Total no. of metabolites 1,061
Reactions
Spontaneous reactions 56
With gene association 761
Without gene association 170
Added reactions 7
Transporters
media 41
Exchange and by-products 18
Biomass 51
Sink 5
Metabolites
Internal metabolites 968
External metabolites 93
pantothenate synthetase, and 2-oxopantoate reductase from
the pantothenate biosynthesis pathway, and nicotinate-
nucleotide diphosphorylase and quinolinate synthetase from the
niacinamide biosynthesis pathway.
3.1.5. Model Analysis—Specification of Minimal
Nutrient Requirements
The model analysis suggests that growth can be supported with
a medium containing only pyruvate, methionine, pantothenate,
and niacinamide (in addition to inorganic salts). Furthermore,
the fact that aspartate, serine, glutamine, and proline were
imported in excess, relative to that required by the biomass
composition, suggests that the presence of these compounds in
the media would enhance growth.
3.2. Experimental Analysis
3.2.1. Media Design and Confirmation of
Auxotrophies
A simplified defined media containing pyruvate, four amino
acids (methionine, cysteine, serine and glutamine or glutamate),
pantothenate, and niacinamide (along with inorganic salts)
supported growth of C. jejuni M1cam. The removal of
methionine, pantothenate and niacinamide from the DMEM/F-
12 media (Table S1) resulted in no growth of M1cam, thus,
confirming auxotrophies predicted by the model analysis.
As part of the media development, the concentration of
sodium pyruvate, as a carbon source, was increased from 0.5 to 10
mM. In addition, the concentrations of auxotrophic substrates,
niacinamide and pantothenate, were optimized to 33.1 and 9.4
µM, respectively (Table 3). The inorganic substrates were kept
identical to those in DMEM/F-12 media. Amino acids cysteine,
serine and glutamine or glutamate, although not essential for
TABLE 3 | Defined media composition designed in this study.
Substrates DMEM/
F-12∗
MM1 MM2 MM3 MM4
Auxotropic
Methionine 115.7 µM 4 mM 4mM 8 mM 6.8 mM
Pantothenate 4.7 µM 9.4 µM 9.4 µM 9.4µM 9.4 µM
Niacinamide 16.6 µM 33.1 µM 33.1 µM 33.1 µM 33.1 µM
Carbon source
Pyruvate 0.5 mM 10 mM 10 mM 10 mM 10 mM
Growth-improving
Cysteine·HCl 100 µM 4 mM 4 mM – 4 mM
Serine 250 µM 10 mM 10 mM 10 mM –
Glutamine 2.5 mM 10 mM – 10 mM 13.6
Glutamate 50 µM – 20 mM – –
Inorganic
salts
same as DMEM/F-12 (Table S1)
Growth (OD 600)
24 h 0.38 ± 0.01 0.31 ± 0.05 0.14 ± 0.03 0.02 ± 0.01 0.15 ± 0.01
48 h 0.34 ± 0.04 1.05 ± 0.06 1.07 ± 0.09 0.41 ± 0.04 0.57 ± 0.01
OD results expressed as mean ± stdev (n = 3).
*Table S1 for all the components of DMEM/F-12.
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growth, had a significant growth promoting effect i.e., removal
of any of these substrates from the media decreased the growth
compared to DMEM/F-12 media. In contrast, removal of any
other amino acids or vitamins did not have any significant effect
on growth as compared to DMEM/F-12 media.
Thus, four simple defined media compositions were defined,
where all four included the auxotrophic substrates, methionine,
pantothenate, and niacinamide along with pyruvate as a carbon
source, and with different combinations of non-essential but
growth-improving organic substrates, presented in Table 3.
The best results, in terms of growth, were obtained when
cysteine, serine, and glutamine or glutamate where present (MM1
and MM2 in Table 3). Individual removal of cysteine and serine
from the media decreased growth to 0.41 ± 0.04 and 0.57 ±
0.01 at 48 h, respectively (MM3 andMM4 in Table 3). Glutamate
and glutamine were exchangeable, having similar effects on
growth (MM1 and MM2 in Table 3). However, removal of both
substrates at the same time resulted in around 4.5 times lower OD
(0.24±0.03 at 48 h, data not shown) when compared to MM1
and MM2. Providing only the essential auxotrophic substrates,
i.e., methionine, pantothenate, and niacinamide, together with
pyruvate as a carbon source and inorganic compounds, did not
support growth (0.05 ± 0.02, data not shown). This confirmed
the impact of each of the growth promoting amino acids in
culturingC. jejuniM1cam. Although each ofMM1 andMM2 had
a similar effect on growth of C. jejuniM1cam, MM1 was selected
as final defined media, as it had a higher starting pH and required
less NaOH to reach pH 7.
Therefore, this media was tested for growth of 7 additional
C. jejuni strains, with the experiments being performed in two
different laboratories, the Department of Veterinary Medicine,
Cambridge University and the London School of Hygiene and
Tropical Medicine. All isolates tested in this study grew in the
designed defined media MM1 by 48 h, using the conditions of
growth as defined by each laboratory, resulting in a range of
OD600 from 0.23 to 1.05 (Table 4). By 48 h, all strains had
reached a plateau and the replicates were stable. The variation in
growth was probably caused by different growth conditions and
the genetics of the strains.
3.2.2. Testing Previously Published Campylobacter
Specific Growth Media
We tested growth of M1cam on the previously published defined
media by Guccione et al. (2010) and Alazzam et al. (2011)
(MCLMAN media). Both formulations did not support growth
of M1cam. MCLMANmedia could support growth only after the
addition of pantothenate, which was confirmed as an auxotrophic
substrate for M1cam in our study. The OD at 600 nm of this
culture (0.33 ± 0.03, data not shown) after 48 h of incubation,
however, was still lower than the growth observed in our defined
media (1.05± 0.06).
4. DISCUSSION AND CONCLUSION
In this study, we have constructed, a well-curated, strain-
specific GSM of C. jejuni M1cam. We have examined the GSM
to investigate the de-novo biosynthesis ability and substrate
TABLE 4 | Growth of different C. jejuni strains in the defined media MM1,
designed in this study.
Labs and Standardized OD600
Culture conditions Strains Inoculum
(cfu/ml)
24 h 48 h
QIBa
Temperature: 37◦C M1cam
(ST 137)
1.73e+09 0.31 ± 0.05 1.05 ± 0.06
Gas mix: 81116
(ST 283)
1.57e+09 0.17 ± 0.10 0.86 ± 0.11
10% O2, 5% CO2,
85% N2
Cambridgeb
Temperature: 42◦C M1cam
(ST 137)
7.63e+07 0.09 ± 0.04 0.75 ± 0.04
Gas mix: calf 3
(ST 514)
4.28e+07 1.01 ± 0.05 1.11 ± 0.10
5% O2, 5% CO2,
5% H2,85% N2
Londonc
11168H
(ST 43)
1.07e+09 0.18 ± 0.12 0.23 ± 0.09
Temperature: 37◦ 81–176
(ST 604)
2.05e+09 0.13 ± 0.02 0.65 ± 0.10
Gas mix:
10% O2, 5% CO2,
85% N2
12912
(HS 50)
8.47e+07 0.34 ± 0.02 0.84 ± 0.12
M1
(ST 137)
6.67e+08 0.07 ± 0.01 0.53 ± 0.12
RM1221
(ST 354)
1.24e+08 0.36 ± 0.04 0.50 ± 0.07
Standardized inoculum (OD = 0.6) colonies formation units/mL (cfu/mL) is expressed as
average of replicates (n= 9). OD results expressed asmean± stdev (n= 9). ST: sequence
type. aQuadram Institute Biosciences, UK. bDepartment of Veterinary Medicine, University
of Cambridge, UK. cLondon School of Hygiene and Tropical Medicine, University of
London, UK.
auxotrophy of the strain. We have experimentally validated the
model results and curated the GSM for missing GPR associations
or over-predicted reactions. A metabolic model guided the
design of a simple defined media for the growth of C. jejuni.
Additionally, we have shown that 8 diverse strains of C. jejuni
are able to grow in the defined simple media.
4.1. Model Analysis
Our analysis showed that when all amino acids are available,
leucine, arginine, histidine, valine, asparagine, phenylalanine,
alanine, threonine, tyrosine, tryptophan, and lysine were
imported at a rate equal to their demand for protein synthesis.
However, the network described by the model has the ability
for the de novo synthesis of these amino acids, as a solution
to Equation 1 could still be found when their respective uptake
transporters were blocked.
In contrast, aspartate, proline, serine, and glutamine were all
taken up at a rate above that required for protein synthesis. It is
worth noting that, without any constraint on media uptake, the
model prefers uptake of aspartate, proline, serine, and glutamine,
which are preferred by C. jejuni and are the most common amino
acids found in chicken excreta (Parsons, 1984). In addition,
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the metabolic profile of C. jejuni liquid cultures’ supernatant
has shown significant depletion of these four amino acids from
nutrient rich medium, reviewed in Hofreuter (2014).
Among all amino acids, serine has been most widely reported
to be preferred by C. jejuni (Guccione et al., 2008; Wright et al.,
2009; Gao et al., 2017). Glutamine utilization in C. jejuni is
known to vary between strains: C. jejuni NCTC11168 has been
reported not to utilize it (Hofreuter et al., 2008), while strains
such as 81116 and 81-176 readily do (Hofreuter et al., 2006).
Aspartate has been shown to be growth promoting under oxygen
limitation (Guccione et al., 2008). Proline utilization has also
been described at the stationary phase of C. jejuni growth, after
the preferred nutrients become exhausted (Wright et al., 2009).
These reports suggest that amino acid utilization varies between
different strains of C. jejuni. It would therefore be necessary to
build a model which represented that variation.
Whilst specific amino acids uptake from media remains
to be tested experimentally for M1cam, similar experimental
observations have been reported by Gao et al. (2017) where C.
jejuni exhibits uptake capacity for amino acids such as arginine,
cysteine, histidine, lysine, phenylalanine, or threonine that are
directly incorporated into synthesized proteins rather than being
catalyzed for energy or conversion to other intermediates.
Model analysis also reveals thatC. jejuniM1camhas the ability
for anaerobic respiration, however, it requires O2 for biomass.
Although model observation is consistent with previous reports
from Sellars et al. (2002), Kelly (2008), van der Stel et al. (2017),
and van der Stel and Wösten (2019), this is a vast research topic
in itself and details remain to be addressed experimentally.
4.2. Auxotrophic Substrates
The modeling and experimental results presented here,
indicate that C. jejuni M1cam is auxotrophic for methionine,
pantothenate, and niacinamide. In this study, we established
that C. jejuni M1cam presents auxotrophy for methionine but
not for cysteine. It can utilize methionine as a S source for
cysteine biosynthesis as also reported in Helicobacter pylorii.
The results presented here suggest that cysteine auxotrophy is
strain dependent and not a conserved metabolic property in all
C. jejuni strains as suggested by Vorwerk et al. (2014). On the
contrary, we found that methionine auxotrophy is maintained
in M1cam even under increased cysteine concentration.
Cysteine, although not auxotrophic, is one of the growth
improving components possibly because of its role in the de
novo synthesis of proteins associated with FeS clusters, such
as the serine dehydratase, pyruvate pyruvate:acceptor and
oxoglutarate:acceptor oxidoreductases. Moreover, most C. jejuni,
as a common feature of host associated epsilonproteobacteria,
are unable to assimilate sulfate as the S source (Alazzam et al.,
2011; Vorwerk et al., 2014) and to compensate for this limited
anabolic capacity, it is reasonable to suggest that Campylobacter
spp. retain auxotrophy (or prefer) S containing amino acids,
methionine, and cysteine.
Auxotrophy for pantothenate, a precursor for CoA synthesis,
is related to host specificity. The pantothenate biosynthesis
gene (panB, panC, and panD) cluster lies in the hypervariable
region (Pearson et al., 2003) and has been shown to be
more frequently present in isolates from cattle compared to
isolates from chickens (Sheppard et al., 2013). C. jejuni M1cam
is the derivative of the human isolate C. jejuni M1 and is
epidemiologically related to poultry strains (Friis et al., 2010;
de Vries et al., 2015); thus, it retains pantothenate auxotrophy.
There is notable differences in C. jejuniM1cam auxotrophy from
that of themore commonly studied strain,C. jejuniNCTC 11168.
The latter presents auxotrophy for methionine and cysteine;
niacinamide, although being growth improving, is not essential
and removal of pantothenate had no effect on growth in this
strain (Alazzam et al., 2011). C. jejuni isolates 81176, on the
other hand, present auxotrophy for cysteine but not methionine
Vorwerk et al. (2014). Differences in substrate auxotrophy
seems to be common among Campylobacter spp.. Tenover and
Patton (1987), based on 439 C. jejuni isolates and 46 C. coli
isolates, have reported Cambylobacter auxotrophy for cysteine,
cystine, arginine, proline, and methionine. The Dickgiesser and
Czylwik (1985) study, based on 52 C. jejuni strains, reported
methionine, cysteine, cystine, panthothenate, thiamine, andNAD
as important substrates for auxotyping of strains.
4.3. Media Design
We have designed simple defined media specifically for C. jejuni
M1cam which can support growth of 7 other C. jejuni strains
tested in this study. The fact that previously reported MCLMAN
media was designed based on C. jejuni NCTC11168 (Alazzam
et al., 2011), which presents a different auxotrophy than C. jejuni
M1cam, and did not include panthothenate, explains why C.
jejuniM1cam growth was not supported in this media.
Our media, apart from C. jejuni M1cam specific auxotrophic
substrates (methionine, pantothenate, niacinamide) and
pyruvate as the carbon source, contains amino acids cysteine,
serine, and glutamate/glutamine. The latter amino acids,
though not essential for growth, had a significant growth
promoting effect on C. jejuni M1cam under our experimental
condition. Similar, reports have been shown for strains 81176
and NCTC11168 where substrates, though not essential,
had to be added to improve growth (Alazzam et al., 2011;
Vorwerk et al., 2014), although preference of these growth
improving substance seems to vary between strains and culture
conditions. This varying amino acid preference suggests their
potential metabolic roles beyond nitrogen and the carbon source
(Bièche et al., 2012). Thus, a detailed study on amino acid
utilization is needed to increase our knowledge in nutrient
acquisition and metabolism of Campylobacter. Although
pyruvate transporters have not been identified, pyruvate has
been shown to be used as an exogenous carbon source when
present in growth medium (Mendz et al., 1997; Velayudhan
and Kelly, 2002; Stahl et al., 2012; Wagley et al., 2014) and have
a protective role in the presence of oxidative stress (Bolton
et al., 1984; Hodge and Krieg, 1994). In our study, increasing
the pyruvate concentration improved growth rate in C. jejuni
M1cam. It should be noted that the media designed in this
study was optimized to maximize the growth of C. jejuni
M1cam. Further tests will be needed to optimize the growth
of other strains, however it is clear that the designed media
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MM1 can support the growth of a variety of strains under
different conditions.
4.4. Conclusion
By adopting a systems-biology approach and using a newly
annotated genome of C. jejuni M1Cam, we have built and
analyzed a strain specific genome-scale model of this organism.
The analysis allowed us to identify specific auxotrophies, as
well as compounds which are preferentially consumed, and
this allowed us to develop a new media suitable for the study
of M1Cam and other Campylobacter spp. strains. The model
analysis also replicated the apparently paradoxical, but widely
reported observation, that although Campylobacter spp. can
operate the electron transport chain in the absence of oxygen,
oxygen is nonetheless essential for growth. Experimentally
confirming all aspects of our model results, in particular the
generation of metabolic by-products in the media, was beyond
the scope of the current contribution. However, we believe
the experimental and modeling results we have presented
here, when taken together, provide a solid foundation upon
which to build further investigations of C. jejuni M1cam and
related organisms.
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